Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies

The coronavirus disease 2019 (COVID-19) has been declared as pandemic by the World Health Organization and is causing substantial morbidity and mortality all over the world. Type 2 diabetes, hypertension, and cardiovascular disease significantly increase the risk for hospitalization and death in COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Longo, Miriam, Caruso, Paola, Maiorino, Maria Ida, Bellastella, Giuseppe, Giugliano, Dario, Esposito, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375203/
https://www.ncbi.nlm.nih.gov/pubmed/32698837
http://dx.doi.org/10.1186/s12933-020-01090-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375203/
https://www.ncbi.nlm.nih.gov/pubmed/32698837
http://dx.doi.org/10.1186/s12933-020-01090-9

Ejemplares similares